Gaughan M - Search Results

1

Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosis.

Gaughan M, Gilligan M, Patterson I, McGurgan I, Yap SM, Tubridy N, McGuigan C. Gaughan M, et al. Mult Scler Relat Disord. 2022 Dec;68:104251. doi: 10.1016/j.msard.2022.104251. Epub 2022 Oct 17. Mult Scler Relat Disord. 2022. PMID: 36283323

2

The accuracy of standard multiple sclerosis MRI brain sequences for the diagnosis of optic neuropathy.

Healy GM, Redmond CE, Gaughan M, Fleming H, Carroll AG, Purcell YM, McGuigan C, McNeill G, Killeen RP. Healy GM, et al. Among authors: gaughan m. Mult Scler Relat Disord. 2020 Feb;38:101521. doi: 10.1016/j.msard.2019.101521. Epub 2019 Nov 12. Mult Scler Relat Disord. 2020. PMID: 31756609

3

Multiscale entropy derived complexity index analysis demonstrates significant mediolateral sway in persons with multiple sclerosis compared to healthy controls.

Etzelmueller MS, Yap SM, O'Keeffe C, Gaughan M, McGuigan C, Reilly RB. Etzelmueller MS, et al. Among authors: gaughan m. Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5176-5179. doi: 10.1109/EMBC44109.2020.9175672. Annu Int Conf IEEE Eng Med Biol Soc. 2020. PMID: 33019151

4

Pediatric Parainfectious Encephalitis Associated With COVID-19.

Gaughan M, Connolly S, O'Riordan S, Tubridy N, McGuigan C, Kinsella JA. Gaughan M, et al. Neurology. 2021 Mar 16;96(11):541-544. doi: 10.1212/WNL.0000000000011476. Epub 2021 Jan 4. Neurology. 2021. PMID: 33397771 No abstract available.

5

Postural stability is a valid and meaningful disability metric in progressive MS with potential for use in neuroprotective therapy trials.

Yap SM, Etzelmueller MS, O'Keeffe C, Gaughan M, Kearney H, Tubridy N, Reilly RB, McGuigan C. Yap SM, et al. Among authors: gaughan m. Mult Scler Relat Disord. 2021 Jul;52:102946. doi: 10.1016/j.msard.2021.102946. Epub 2021 Apr 11. Mult Scler Relat Disord. 2021. PMID: 33901968

6

Skin care advice to patients with multiple sclerosis on Fingolimod treatment at increased risk of skin malignancy-room for improvement?

O'Higgins L, Gaughan M, McGuigan C, Lally A. O'Higgins L, et al. Among authors: gaughan m. Ir J Med Sci. 2022 Aug;191(4):1683-1685. doi: 10.1007/s11845-021-02768-z. Epub 2021 Sep 8. Ir J Med Sci. 2022. PMID: 34495479

7

Vaccine hesitancy among people with multiple sclerosis.

Yap SM, Al Hinai M, Gaughan M, Callanan I, Kearney H, Tubridy N, McGuigan C. Yap SM, et al. Among authors: gaughan m. Mult Scler Relat Disord. 2021 Nov;56:103236. doi: 10.1016/j.msard.2021.103236. Epub 2021 Sep 2. Mult Scler Relat Disord. 2021. PMID: 34507240 Free PMC article.

8

Five-year follow up of the original Irish BICAMS validation cohort.

Gaughan M, Monaghan R, O'Connell K, McNicholas N, Yap SM, Tubridy N, O'Keeffe F, McGuigan C. Gaughan M, et al. Mult Scler Relat Disord. 2021 Nov;56:103257. doi: 10.1016/j.msard.2021.103257. Epub 2021 Sep 17. Mult Scler Relat Disord. 2021. PMID: 34619486

9

Investigating the association of mood and fatigue with objective and subjective cognitive impairment in multiple sclerosis.

Davenport L, Cogley C, Monaghan R, Gaughan M, Yap M, Bramham J, Tubridy N, McGuigan C, O'Keeffe F. Davenport L, et al. Among authors: gaughan m. J Neuropsychol. 2022 Sep;16(3):537-554. doi: 10.1111/jnp.12283. Epub 2022 Jun 28. J Neuropsychol. 2022. PMID: 35765743

10

Word finding, prosody and social cognition in multiple sclerosis.

Yap SM, Davenport L, Cogley C, Craddock F, Kennedy A, Gaughan M, Kearney H, Tubridy N, De Looze C, O'Keeffe F, Reilly RB, McGuigan C. Yap SM, et al. Among authors: gaughan m. J Neuropsychol. 2023 Mar;17(1):32-62. doi: 10.1111/jnp.12285. Epub 2022 Jul 12. J Neuropsychol. 2023. PMID: 35822290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters